摘要为了提升临床医师对肝、肾移植受者霉酚酸类药物应用的认识，进一步规范霉酚酸类药物的临床应用，建立临床实践中不同霉酚酸类药物替换的基本原则，中华医学会器官移植学分会、中国医师协会器官移植医师分会和上海医药行业协会基于循证医学证据和临床实践经验形成此共识，希望能为肝、肾移植受者霉酚酸类药物的临床应用提供依据。

abstractsTo enhance clinical physicians' understanding of the use of mycophenolic acid in liver and kidney transplant recipients, further standardize the clinical use of mycophenolic acid, and establish basic principles for the switch of mycophenolic acids of different brands and formulations in clinical practice.This consensus, grounded in both evidence and clinical experience, has been collaboratively developed by the Branch of Organ Transplant of Chinese Medical Association, the Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, and the Shanghai Pharmaceutical Profession Association.The overarching hope is that this document will serve as a foundational reference for the clinical application of mycophenolic acids in liver and kidney transplant scenarios.